Ribavirin Capsules Recalled for Potential Labeling Mixup
Aidapak Services is recalling Ribavirin capsules that may be mislabeled as Modafinil or Desipramine. The error involves incorrect product identification on the packaging.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a moderate severity score. The hazard is a labeling mixup, which is a significant error but does not involve a direct physical defect or reported illness in the source text.
Plain-English summary
Aidapak Services, LLC is recalling Ribavirin, Capsule, 200 mg, NDC 68382026007. The recall is due to a labeling mixup where the product may be potentially mislabeled as Modafinil, Tablet, 50 mg, or Desipramine HCL, Tablet, 50 mg.
The affected Ribavirin capsules have the following pedigree codes and expiration dates: Pedigree AD21790_37, EXP 4/30/2014, and Pedigree AD30140_13, EXP 4/30/2014. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Consumers and healthcare providers should check their inventory for these specific pedigree codes and expiration dates. If the product is found, it should be returned to the distributor or the recalling firm for credit. Patients should consult their healthcare provider if they have questions regarding their medication.
The recalled product
- Product
- RIBAVIRIN, Capsule, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 68382026007
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 168
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- RIBAVIRIN
- Capsule
- 200 mg has the following codes Pedigree: AD21790_37
- EXP: 4/30/2014
- Pedigree: AD30140_13
- EXP: 4/30/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls Modafinil Tablets Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- HighAidapak Recalls Acyclovir Capsules Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Aspirin/ER Dipyridamole Capsules Due to Labeling Error
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Gabapentin Tablets Due to Potential Labeling Error
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Dicyclomine HCL Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- SevereFDA Recalls Efavirenz Capsules Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29